Leidos (LDOS) Financials

Leidos logo
$128.20 -1.83 (-1.40%)
Closing price 11/17/2026 03:59 PM Eastern
Extended Trading
$127.61 -0.58 (-0.46%)
As of 07:55 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Leidos

Annual Income Statements for Leidos

This table shows Leidos' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/30/2015 12/30/2016 12/29/2017 12/28/2018 1/3/2020 1/1/2021 12/31/2021 12/30/2022 12/29/2023 1/3/2025 1/2/2026
Net Income / (Loss) Attributable to Common Shareholders
-323 244 366 581 667 628 753 685 199 1,254 1,448
Consolidated Net Income / (Loss)
-323 246 364 582 670 629 759 693 208 1,251 1,462
Net Income / (Loss) Continuing Operations
-330 246 364 582 670 629 759 693 208 1,251 1,462
Total Pre-Tax Income
-283 318 393 610 866 781 967 886 403 1,639 1,909
Total Operating Income
-214 407 559 731 912 984 1,152 1,088 621 1,827 2,109
Total Gross Profit
666 937 1,432 1,504 1,548 1,737 2,014 2,084 2,244 2,798 3,099
Total Revenue
5,063 7,043 10,170 10,194 11,094 12,297 13,737 14,396 15,438 16,662 17,174
Operating Revenue
5,063 7,043 10,170 10,194 11,094 12,297 13,737 14,396 15,438 16,662 17,174
Total Cost of Revenue
4,397 6,106 8,738 8,690 9,546 10,560 11,723 12,312 13,194 13,864 14,075
Operating Cost of Revenue
4,392 6,103 8,738 8,690 9,546 10,560 11,723 12,312 13,194 13,864 14,075
Total Operating Expenses
880 530 873 773 636 753 858 1,008 1,653 960 985
Selling, General & Admin Expense
310 422 737 729 689 770 851 951 942 983 999
Other Operating Expenses / (Income)
- - -3.00 0.00 -58 -68 -20 - - -39 -32
Impairment Charge
567 4.00 0.00 7.00 0.00 12 - 40 687 0.00 0.00
Restructuring Charge
3.00 104 139 37 5.00 39 27 17 24 16 18
Total Other Income / (Expense), net
-69 -89 -166 -121 -46 -203 -185 -190 -188 -188 -200
Interest & Investment Income
1.00 10 - 18 - 14 - -187 -182 -193 -203
Other Income / (Expense), net
5.00 -13 -26 -1.00 87 -38 -1.00 -3.00 -6.00 5.00 3.00
Income Tax Expense
47 72 29 28 196 152 208 193 195 388 447
Net Income / (Loss) Attributable to Noncontrolling Interest
0.00 2.00 -2.00 1.00 3.00 1.00 6.00 8.00 9.00 -3.00 14
Basic Earnings per Share
($4.36) $2.39 $2.41 $3.85 $4.66 $4.42 $5.34 $5.00 $1.45 $9.36 $11.31
Weighted Average Basic Shares Outstanding
74.13M 102M 151.46M 146.16M 141.40M 141.89M 140.51M 136.94M 135.78M 131.17M 126.39M
Diluted Earnings per Share
($4.36) $2.35 $2.38 $3.80 $4.60 $4.36 $5.27 $4.96 $1.44 $9.22 $11.14
Weighted Average Diluted Shares Outstanding
74.13M 102M 151.46M 146.16M 141.40M 141.89M 140.51M 136.94M 135.78M 131.17M 126.39M
Weighted Average Basic & Diluted Shares Outstanding
74.13M 102M 151.46M 146.16M 141.40M 141.89M 140.51M 136.94M 135.78M 131.17M 126.39M
Cash Dividends to Common per Share
$1.28 $1.28 $1.28 $1.28 $1.32 $1.36 $1.40 $1.44 $1.46 $1.54 $1.63

Quarterly Income Statements for Leidos

This table shows Leidos' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/29/2024 6/28/2024 9/27/2024 1/3/2025 4/4/2025 7/4/2025 10/3/2025 1/2/2026 4/3/2026 7/3/2026 10/2/2026
Net Income / (Loss) Attributable to Common Shareholders
284 322 364 284 363 391 367 327 328 354 410
Consolidated Net Income / (Loss)
283 324 362 282 365 393 369 335 335 356 413
Net Income / (Loss) Continuing Operations
283 324 362 282 365 393 369 335 335 356 413
Total Pre-Tax Income
368 426 470 375 478 518 484 429 429 451 482
Total Operating Income
415 475 516 421 530 571 535 473 508 514 553
Total Gross Profit
638 705 762 693 757 782 821 739 761 817 820
Total Revenue
3,975 4,132 4,190 4,365 4,245 4,253 4,469 4,207 4,400 4,558 4,630
Operating Revenue
3,975 4,132 4,190 4,365 4,245 4,253 4,469 4,207 4,400 4,558 4,630
Total Cost of Revenue
3,337 3,427 3,428 3,672 3,488 3,471 3,648 3,468 3,639 3,741 3,810
Operating Cost of Revenue
3,337 3,427 3,428 3,672 3,488 3,471 3,648 3,468 3,639 3,741 3,810
Total Operating Expenses
223 230 256 251 227 211 286 265 253 303 267
Selling, General & Admin Expense
226 231 247 279 230 217 290 266 223 283 262
Other Operating Expenses / (Income)
-7.00 -8.00 - - -7.00 -8.00 -8.00 -9.00 -5.00 -7.00 -7.00
Restructuring Charge
4.00 7.00 3.00 2.00 4.00 2.00 4.00 8.00 35 27 12
Total Other Income / (Expense), net
-47 -49 -36 -56 -52 -53 -51 -44 -79 -63 -71
Interest & Investment Income
-49 -51 -36 - -49 -55 -51 -48 -55 -69 -67
Other Income / (Expense), net
2.00 2.00 0.00 1.00 -3.00 2.00 0.00 4.00 -24 6.00 -4.00
Income Tax Expense
85 102 108 93 113 125 115 94 94 95 69
Net Income / (Loss) Attributable to Noncontrolling Interest
-1.00 2.00 -2.00 -2.00 2.00 2.00 2.00 8.00 7.00 2.00 3.00
Basic Earnings per Share
$2.09 $2.39 $2.72 $2.16 $2.79 $3.03 $2.87 $2.62 $2.60 $2.81 $3.31
Weighted Average Basic Shares Outstanding
135.21M 134.71M 133.43M 131.17M 128.72M 128.30M 127.86M 126.39M 125.79M 125.49M 121.99M
Diluted Earnings per Share
$2.07 $2.37 $2.68 $2.10 $2.77 $3.01 $2.82 $2.54 $2.56 $2.81 $3.28
Weighted Average Diluted Shares Outstanding
135.21M 134.71M 133.43M 131.17M 128.72M 128.30M 127.86M 126.39M 125.79M 125.49M 121.99M
Weighted Average Basic & Diluted Shares Outstanding
135.21M 134.71M 133.43M 131.17M 128.72M 128.30M 127.86M 126.39M 125.79M 125.49M 121.99M

Annual Cash Flow Statements for Leidos

This table details how cash moves in and out of Leidos' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/30/2015 12/30/2016 12/29/2017 12/28/2018 1/3/2020 1/1/2021 12/31/2021 12/30/2022 12/29/2023 1/3/2025 1/2/2026
Net Change in Cash & Equivalents
13 -277 26 -53 348 -30 188 -192 267 199 213
Net Cash From Operating Activities
396 449 526 768 992 1,334 1,033 992 1,187 1,435 1,750
Net Cash From Continuing Operating Activities
396 449 526 768 992 1,334 1,033 992 1,187 1,435 1,750
Net Income / (Loss) Continuing Operations
-330 246 364 582 670 629 759 693 208 1,251 1,462
Consolidated Net Income / (Loss)
-323 246 364 582 670 629 759 693 208 1,251 1,462
Depreciation Expense
62 122 336 257 234 282 325 333 331 290 290
Non-Cash Adjustments To Reconcile Net Income
617 39 107 69 -21 124 64 139 792 140 109
Changes in Operating Assets and Liabilities, net
47 42 -295 -140 109 299 -115 -173 -144 -246 -111
Net Cash From Investing Activities
51 25 -71 -114 65 -2,815 -730 -313 -211 -142 -405
Net Cash From Continuing Investing Activities
51 26 -71 -114 65 -2,815 -730 -313 -211 -142 -405
Purchase of Property, Plant & Equipment
-29 -29 -81 -73 -121 -183 -104 -129 -207 -149 -125
Acquisitions
0.00 25 0.00 -81 -94 -2,655 -622 -192 -6.00 0.00 -293
Divestitures
0.00 23 0.00 0.00 178 0.00 0.00 15 2.00 0.00 9.00
Other Investing Activities, net
80 - 0.00 0.00 1.00 11 -4.00 -13 0.00 7.00 4.00
Net Cash From Financing Activities
-478 -751 -429 -707 -709 1,451 -113 -865 -715 -1,084 -1,145
Net Cash From Continuing Financing Activities
-478 -751 -429 -707 -709 1,451 -113 -865 -715 -1,084 -1,145
Repayment of Debt
-175 -307 -213 -76 -80 -5,512 -106 -545 -2,052 -19 -1,033
Repurchase of Common Equity
-215 -24 -31 -438 -458 -105 -270 -542 -246 -906 -944
Payment of Dividends
-95 -1,135 -198 -198 -198 -192 -161 -206 -210 -214 -227
Issuance of Debt
0.00 690 - 0.00 0.00 7,225 380 380 1,743 0.00 997
Issuance of Common Equity
7.00 25 13 14 27 35 44 48 50 55 62
Effect of Exchange Rate Changes
- - - - - - -2.00 -6.00 6.00 -10 13
Cash Interest Paid
- - - - 172 161 182 195 207 226 220
Cash Income Taxes Paid
- - - - 142 140 221 217 435 460 276

Quarterly Cash Flow Statements for Leidos

This table details how cash moves in and out of Leidos' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/29/2024 6/28/2024 9/27/2024 1/3/2025 4/4/2025 7/4/2025 10/3/2025 1/2/2026 4/3/2026 7/3/2026 10/2/2026
Net Change in Cash & Equivalents
-131 194 385 -242 -67 96 77 107 -666 333 -74
Net Cash From Operating Activities
113 374 656 299 58 486 711 495 301 793 523
Net Cash From Continuing Operating Activities
113 374 656 299 58 486 711 495 301 793 523
Net Income / (Loss) Continuing Operations
283 324 362 282 365 393 369 335 335 356 413
Consolidated Net Income / (Loss)
283 324 362 282 365 393 369 335 335 356 413
Depreciation Expense
69 71 71 79 69 72 74 75 72 81 76
Non-Cash Adjustments To Reconcile Net Income
14 28 28 70 20 26 33 30 58 27 41
Changes in Operating Assets and Liabilities, net
-253 -49 195 -132 -396 -5.00 235 55 -164 329 -7.00
Net Cash From Investing Activities
-12 -21 -23 -86 -22 -314 -36 -33 -2,359 -38 -48
Net Cash From Continuing Investing Activities
-12 -21 -23 -86 -22 -314 -36 -33 -2,359 -38 -48
Purchase of Property, Plant & Equipment
-17 -23 -23 -86 -22 -29 -31 -43 -31 -32 -47
Other Investing Activities, net
5.00 - - - 0.00 - 2.00 2.00 6.00 -10 -1.00
Net Cash From Financing Activities
-228 -159 -257 -440 -110 -83 -595 -357 1,393 -423 -549
Net Cash From Continuing Financing Activities
-228 -159 -257 -440 -110 -83 -595 -357 1,393 -423 -549
Repayment of Debt
-4.00 -5.00 -5.00 -5.00 -536 -36 -456 -5.00 -20 -12 -5.00
Repurchase of Common Equity
-183 -114 -203 -406 -528 -9.00 -102 -305 -243 -72 -504
Payment of Dividends
-54 -53 -51 -56 -58 -54 -53 -62 -57 -56 -54
Issuance of Common Equity
13 13 2.00 27 15 16 16 15 16 17 14
Cash Interest Paid
61 46 60 59 51 49 77 43 68 44 102
Cash Income Taxes Paid
2.00 161 113 184 -4.00 166 17 97 -5.00 14 22

Annual Balance Sheets for Leidos

This table presents Leidos' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/1/2016 12/30/2016 12/29/2017 12/28/2018 1/3/2020 1/1/2021 12/31/2021 12/30/2022 12/29/2023 1/3/2025 1/2/2026
Total Assets
3,370 9,132 8,990 8,770 9,367 12,511 13,261 13,071 12,695 13,010 13,493
Total Current Assets
1,793 2,381 2,674 2,839 2,812 3,339 3,619 3,643 4,005 4,334 4,814
Cash & Equivalents
656 376 390 327 668 524 727 516 777 849 1,108
Accounts Receivable
921 1,657 1,831 1,877 1,734 2,137 2,189 2,350 2,429 2,645 2,708
Inventories, net
- - - - 72 276 274 287 310 315 342
Other Current Assets
- - 453 543 338 402 429 490 489 525 656
Other Current Nonoperating Assets
- - - 92 - - - - - - 0.00
Plant, Property, & Equipment, net
142 259 232 237 0.00 0.00 670 847 961 991 961
Total Noncurrent Assets
1,435 6,476 6,084 5,694 6,555 9,172 8,972 8,581 7,729 7,685 7,718
Goodwill
1,207 4,622 4,974 4,860 4,912 6,313 6,744 6,696 6,112 6,084 6,342
Intangible Assets
25 1,589 856 652 530 1,216 1,177 952 667 517 458
Other Noncurrent Operating Assets
195 265 254 182 1,113 1,643 1,051 933 950 881 918
Total Liabilities & Shareholders' Equity
3,370 9,132 8,990 8,770 9,367 12,511 13,261 13,071 12,695 13,010 13,493
Total Liabilities
2,302 5,985 5,607 5,459 5,950 8,640 8,917 8,718 8,437 8,550 8,531
Total Current Liabilities
1,040 2,016 2,202 2,059 2,333 2,907 3,229 3,947 2,990 3,560 2,827
Short-Term Debt
2.00 62 55 72 61 100 483 992 18 618 20
Accounts Payable
761 1,427 1,639 1,491 1,837 2,175 2,141 2,254 2,277 2,131 1,988
Current Employee Benefit Liabilities
268 483 487 473 435 632 605 701 695 811 819
Other Current Nonoperating Liabilities
1.00 - - 23 - - - - - - 0.00
Total Noncurrent Liabilities
1,262 3,969 3,405 3,400 3,617 5,733 5,688 4,771 5,447 4,990 5,704
Long-Term Debt
1,079 3,225 3,056 3,052 2,925 4,644 4,593 3,928 4,664 4,052 4,628
Other Noncurrent Operating Liabilities
149 204 129 178 508 855 856 803 783 936 1,076
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,068 3,147 3,383 3,311 3,417 3,871 4,344 4,353 4,258 4,460 4,962
Total Preferred & Common Equity
1,068 3,135 3,370 3,308 3,413 3,862 4,291 4,299 4,201 4,412 4,916
Total Common Equity
1,068 3,135 3,370 3,308 3,413 3,862 4,291 4,299 4,201 4,412 4,916
Common Stock
1,353 3,316 3,344 2,966 2,587 2,580 2,423 2,005 1,885 1,112 319
Retained Earnings
-277 -177 -7.00 372 896 1,328 1,880 2,367 2,364 3,410 4,647
Accumulated Other Comprehensive Income / (Loss)
-8.00 -4.00 33 -30 -70 -46 -12 -73 -48 -110 -50
Noncontrolling Interest
0.00 12 13 3.00 4.00 9.00 53 54 57 48 46

Quarterly Balance Sheets for Leidos

This table presents Leidos' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 12/29/2023 3/29/2024 6/28/2024 9/27/2024 1/3/2025 4/4/2025 7/4/2025 10/3/2025 4/3/2026 7/3/2026 10/2/2026
Total Assets
12,695 12,817 12,909 13,338 13,104 13,197 13,549 13,542 15,387 15,632 15,466
Total Current Assets
4,005 4,150 4,229 4,665 4,428 4,549 4,781 4,849 4,403 5,246 5,080
Cash & Equivalents
777 633 823 1,185 943 842 930 974 457 748 630
Accounts Receivable
2,429 2,713 2,615 2,706 2,645 2,906 2,915 2,970 3,028 2,968 2,944
Inventories, net
310 318 333 323 315 347 364 360 336 94 90
Other Current Assets
489 486 458 451 525 454 572 545 582 493 512
Other Current Nonoperating Assets
- - - - - - - - - 943 904
Plant, Property, & Equipment, net
961 972 984 992 991 977 973 963 966 900 913
Total Noncurrent Assets
7,729 7,695 7,696 7,681 7,685 7,671 7,795 7,730 10,018 9,486 9,473
Goodwill
6,112 6,099 6,102 6,123 6,084 6,098 6,359 6,342 8,094 7,663 7,725
Intangible Assets
667 629 592 558 517 489 515 496 993 943 879
Other Noncurrent Operating Assets
950 967 1,002 1,000 1,084 1,084 921 860 896 880 869
Total Liabilities & Shareholders' Equity
12,695 12,817 12,909 13,338 13,104 13,197 13,549 13,542 15,387 15,632 15,466
Total Liabilities
8,437 8,504 8,399 8,671 8,644 8,895 8,842 8,588 10,323 10,296 10,241
Total Current Liabilities
2,990 3,084 3,505 3,782 3,654 2,961 2,948 2,986 3,152 3,220 3,177
Short-Term Debt
18 43 567 592 618 119 119 19 320 22 18
Accounts Payable
2,277 2,301 2,235 2,287 2,225 2,178 2,003 2,158 2,145 2,180 2,175
Current Employee Benefit Liabilities
695 740 703 903 811 664 826 809 687 855 813
Other Current Nonoperating Liabilities
- - - - - - - - - 163 171
Total Noncurrent Liabilities
5,447 5,420 4,894 4,889 4,990 5,934 5,894 5,602 7,171 7,076 7,064
Long-Term Debt
4,664 4,636 4,109 4,081 4,052 5,014 4,985 4,632 6,014 6,009 6,009
Other Noncurrent Operating Liabilities
783 784 785 808 938 920 909 848 877 1,067 1,055
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
4,258 4,313 4,510 4,667 4,460 4,302 4,707 4,954 5,064 5,336 5,225
Total Preferred & Common Equity
4,201 4,258 4,455 4,614 4,412 4,257 4,662 4,909 5,013 5,284 5,172
Total Common Equity
4,201 4,258 4,455 4,614 4,412 4,257 4,662 4,909 5,013 5,284 5,172
Common Stock
1,885 1,735 1,654 1,469 1,112 619 650 588 117 88 0.00
Retained Earnings
2,364 2,595 2,866 3,179 3,410 3,721 4,061 4,375 4,921 5,219 5,197
Accumulated Other Comprehensive Income / (Loss)
-48 -72 -65 -34 -110 -83 -49 -54 -25 -23 -25
Noncontrolling Interest
57 55 55 53 48 45 45 45 51 52 53

Annual Metrics And Ratios for Leidos

This table displays calculated financial ratios and metrics derived from Leidos' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/30/2015 12/30/2016 12/29/2017 12/28/2018 1/3/2020 1/1/2021 12/31/2021 12/30/2022 12/29/2023 1/3/2025 1/2/2026
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-12.02% 39.11% 44.40% 0.24% 8.83% 10.84% 23.42% 4.80% 7.24% 7.93% 3.07%
EBITDA Growth
-162.55% 451.02% 71.12% 11.78% 24.92% -0.41% 20.20% -7.36% -33.29% 124.31% 13.20%
EBIT Growth
-234.84% 288.52% 35.28% 36.96% 36.85% -5.31% 21.67% -5.73% -43.32% 197.89% 15.28%
NOPAT Growth
-196.28% 310.18% 64.44% 34.71% 1.17% 12.32% 28.19% -11.16% -62.34% 335.08% 15.82%
Net Income Growth
-296.95% 176.16% 47.97% 59.89% 15.12% -6.12% 20.67% -8.70% -69.99% 501.44% 16.87%
EPS Growth
-324.74% 153.90% 1.28% 59.66% 21.05% -5.22% 41.74% -11.76% -70.97% 540.28% 20.82%
Operating Cash Flow Growth
28.16% 13.38% 17.15% 46.01% 29.17% 34.48% -22.56% -7.94% 17.44% 19.49% 21.95%
Free Cash Flow Firm Growth
410.31% -628.99% 110.85% 68.80% 29.53% -254.87% 238.66% 331.83% 16.20% 49.86% 9.22%
Invested Capital Growth
-77.88% 305.41% 0.92% -1.34% -5.03% 41.08% 7.44% 1.47% -6.78% 0.29% 2.67%
Revenue Q/Q Growth
-8.31% 23.00% -0.58% 1.30% 0.00% 2.48% 3.54% 2.90% 1.87% 2.37% -0.91%
EBITDA Q/Q Growth
-120.14% 919.05% -3.29% 8.58% 0.00% 1.40% 0.07% 0.14% 10.64% 2.86% 2.17%
EBIT Q/Q Growth
-261.56% 373.61% -9.81% 15.14% 0.00% 0.96% -1.03% 1.69% 17.59% 3.56% 2.67%
NOPAT Q/Q Growth
-245.60% 410.20% 29.83% 2.50% 0.00% 2.01% -1.91% 2.65% 20.63% 3.60% 3.38%
Net Income Q/Q Growth
-292.95% 193.18% 17.04% 14.79% 0.00% 2.61% -5.38% 1.16% 31.65% 4.34% 3.76%
EPS Q/Q Growth
-290.36% 158.60% 23.96% 15.15% 0.00% 2.35% -2.41% 2.45% 35.85% 4.77% 4.11%
Operating Cash Flow Q/Q Growth
-52.05% 29.77% 8.90% -7.25% 0.00% -14.21% 68.66% -8.06% 18.15% -0.36% 16.20%
Free Cash Flow Firm Q/Q Growth
-53.49% 11.57% 7.94% -13.92% 249.34% -18.35% 1,172.35% -67.16% 98.07% 3.12% 28.33%
Invested Capital Q/Q Growth
4.23% -1.77% -0.39% 2.01% 1.85% 4.68% 0.16% 10.15% 0.31% 0.39% -1.49%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
26.31% 13.30% 14.08% 14.75% 13.95% 14.13% 29.32% 28.95% 14.54% 16.79% 18.04%
EBITDA Margin
-5.81% 7.33% 8.68% 9.68% 11.11% 9.99% 10.74% 19.70% 6.13% 12.74% 13.99%
Operating Margin
-4.23% 5.78% 5.50% 7.17% 8.22% 8.00% 16.77% 7.56% 4.02% 10.97% 12.28%
EBIT Margin
-8.26% 5.59% 5.24% 7.16% 9.00% 7.69% 16.76% 15.07% 3.98% 11.00% 12.30%
Profit (Net Income) Margin
-12.76% 3.49% 3.58% 5.71% 6.04% 5.12% 5.53% 4.81% 1.35% 7.51% 8.51%
Tax Burden Percent
114.13% 77.36% 92.62% 95.41% 77.37% 80.54% 78.49% 156.43% 51.61% 76.33% 76.58%
Interest Burden Percent
135.41% 80.71% 73.73% 83.56% 86.69% 82.56% 169.51% 164.23% 65.53% 89.47% 90.39%
Effective Tax Rate
0.00% 22.64% 7.38% 4.59% 22.63% 19.46% 43.02% 43.57% 48.39% 23.67% 23.42%
Return on Invested Capital (ROIC)
-15.19% 8.33% 8.50% 11.47% 11.99% 11.46% 21.55% 9.75% 3.79% 17.06% 19.25%
ROIC Less NNEP Spread (ROIC-NNEP)
-69.18% 4.21% 3.06% 7.25% 10.58% 6.46% 14.95% 6.14% 1.08% 13.30% 15.09%
Return on Net Nonoperating Assets (RNNOA)
-33.33% 3.34% 2.65% 5.92% 7.93% 5.80% 7.70% 12.47% 1.04% 11.64% 11.79%
Return on Equity (ROE)
-48.52% 11.67% 11.15% 17.39% 19.92% 17.26% 36.96% 31.87% 4.83% 28.70% 31.03%
Cash Return on Invested Capital (CROIC)
81.52% -112.53% 7.58% 12.82% 17.15% -22.62% 7.20% 18.04% 10.81% 16.76% 16.61%
Operating Return on Assets (OROA)
-5.55% 6.30% 5.88% 8.22% 11.02% 8.65% 17.86% 16.48% 4.77% 14.20% 15.94%
Return on Assets (ROA)
-17.15% 3.94% 4.02% 6.55% 7.39% 5.75% 11.78% 10.53% 1.61% 9.70% 11.03%
Return on Common Equity (ROCE)
-24.26% 11.64% 11.11% 17.35% 19.90% 17.23% 18.34% 31.48% 4.77% 28.35% 30.72%
Return on Equity Simple (ROE_SIMPLE)
-60.49% 7.85% 10.80% 17.59% 19.63% 16.29% 35.38% 32.24% 4.95% 28.35% 0.00%
Net Operating Profit after Tax (NOPAT)
-150 315 518 697 706 792 904 851 321 1,394 1,615
NOPAT Margin
-2.96% 4.47% 5.09% 6.84% 6.36% 6.44% 6.58% 11.82% 2.08% 8.37% 9.40%
Net Nonoperating Expense Percent (NNEP)
54.00% 4.12% 5.44% 4.22% 1.41% 5.00% 6.78% 7.22% 2.71% 3.76% 4.16%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 9.18% 3.59% 15.27% 16.81%
Cost of Revenue to Revenue
86.85% 86.70% 85.92% 85.25% 86.05% 85.87% 170.68% 171.05% 85.46% 83.21% 81.96%
SG&A Expenses to Revenue
12.25% 5.99% 7.25% 7.15% 6.21% 6.26% 12.46% 13.21% 6.10% 5.90% 5.82%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
34.76% 7.53% 8.58% 7.58% 5.73% 6.12% 12.67% 14.00% 10.71% 5.76% 5.74%
Earnings before Interest and Taxes (EBIT)
-209 394 533 730 999 946 1,151 1,085 615 1,832 2,112
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-147 516 883 987 1,233 1,228 1,476 1,418 946 2,122 2,402
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.56 2.16 2.61 2.18 3.86 3.68 2.80 6.60 3.51 4.45 4.77
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.37 0.96 0.87 0.71 1.19 1.15 0.87 1.97 0.95 1.18 1.37
Price to Earnings (P/E)
0.00 27.78 24.06 12.42 19.75 22.61 15.95 20.45 74.00 15.66 16.20
Dividend Yield
5.04% 33.10% 2.20% 2.66% 1.42% 1.36% 3.27% 2.81% 1.36% 1.05% 0.89%
Earnings Yield
0.00% 3.60% 4.16% 8.05% 5.06% 4.42% 6.27% 4.89% 1.35% 6.39% 6.17%
Enterprise Value to Invested Capital (EV/IC)
3.11 1.60 1.89 1.66 2.70 2.28 3.81 4.26 2.29 2.86 3.18
Enterprise Value to Revenue (EV/Rev)
0.92 1.38 1.13 0.98 1.40 1.50 2.41 2.59 1.21 1.41 1.57
Enterprise Value to EBITDA (EV/EBITDA)
0.00 18.80 13.07 10.15 12.56 15.00 22.57 26.40 19.75 11.03 11.26
Enterprise Value to EBIT (EV/EBIT)
0.00 24.62 21.65 13.72 15.51 19.48 14.26 17.02 30.39 12.78 12.80
Enterprise Value to NOPAT (EV/NOPAT)
0.00 30.81 22.29 14.36 21.96 23.25 18.15 44.04 58.30 16.79 16.74
Enterprise Value to Operating Cash Flow (EV/OCF)
5.83 21.61 21.94 13.04 15.62 13.81 15.89 18.61 16.04 16.82 15.45
Enterprise Value to Free Cash Flow (EV/FCFF)
5.79 0.00 24.99 12.85 15.35 0.00 112.48 23.46 20.43 17.08 19.40
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
2.02 1.04 0.92 0.94 0.87 1.23 2.34 2.26 1.10 1.05 0.94
Long-Term Debt to Equity
1.01 1.02 0.90 0.92 0.86 1.20 2.11 1.80 1.10 0.91 0.93
Financial Leverage
0.96 0.79 0.87 0.82 0.75 0.90 2.09 2.01 0.96 0.88 0.78
Leverage Ratio
5.66 2.97 2.78 2.65 2.70 3.00 6.27 6.06 2.99 2.96 2.81
Compound Leverage Factor
7.66 2.39 2.05 2.22 2.34 2.48 5.32 4.97 1.96 2.65 2.54
Debt to Total Capital
100.61% 51.09% 47.91% 48.55% 46.63% 55.07% 53.89% 53.06% 52.37% 51.15% 48.37%
Short-Term Debt to Total Capital
0.09% 0.96% 0.85% 1.12% 0.95% 1.16% 10.25% 10.70% 0.20% 6.77% 0.21%
Long-Term Debt to Total Capital
50.21% 50.12% 47.06% 47.43% 45.68% 53.91% 97.52% 84.72% 52.17% 44.38% 48.16%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.19% 0.20% 0.05% 0.06% 0.10% 0.56% 1.16% 0.64% 0.53% 0.48%
Common Equity to Total Capital
49.70% 48.73% 51.89% 51.41% 53.30% 44.83% 45.55% 92.72% 46.99% 48.32% 51.16%
Debt to EBITDA
-14.71 6.37 3.52 3.17 2.42 3.86 6.93 3.47 4.95 2.20 1.94
Net Debt to EBITDA
-5.78 5.64 3.08 2.83 1.88 3.44 5.93 6.24 4.13 1.76 1.47
Long-Term Debt to EBITDA
-14.68 6.25 3.46 3.09 2.37 3.78 3.11 2.77 4.93 1.91 1.93
Debt to NOPAT
-14.43 10.44 6.01 4.48 4.23 5.99 11.33 11.63 14.61 3.35 2.88
Net Debt to NOPAT
-5.67 9.25 5.26 4.01 3.29 5.33 4.81 5.18 12.18 2.67 2.19
Long-Term Debt to NOPAT
-14.41 10.24 5.90 4.38 4.15 5.86 5.08 9.28 14.55 2.91 2.87
Altman Z-Score
3.89 1.61 2.33 2.40 3.06 2.41 4.74 5.15 2.78 3.53 4.10
Noncontrolling Interest Sharing Ratio
0.00% 0.28% 0.38% 0.24% 0.10% 0.18% 1.51% 2.46% 1.29% 1.20% 1.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.72 1.18 1.21 1.38 1.21 1.15 2.24 1.85 1.34 1.21 1.70
Quick Ratio
3.03 1.01 1.01 1.07 1.03 0.92 0.90 1.45 1.07 0.98 1.35
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
804 -4,254 462 779 1,010 -1,564 302 787 915 1,370 1,394
Operating Cash Flow to CapEx
1,365.52% 1,726.92% 720.55% 1,052.05% 3,968.00% 780.12% 1,986.54% 1,613.01% 562.80% 946.94% 1,400.00%
Free Cash Flow to Firm to Interest Expense
10.72 -49.47 3.30 5.65 7.59 -8.73 1.64 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
5.28 5.22 3.76 5.57 7.46 7.45 11.23 4.98 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
9.79 4.92 3.24 5.04 7.27 6.50 10.10 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
2.69 1.13 1.12 1.15 1.22 1.12 1.07 2.19 1.20 1.29 1.30
Accounts Receivable Turnover
10.11 5.46 5.83 5.50 6.14 6.35 12.70 12.69 6.46 6.57 6.42
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 60.69 42.63 43.89 44.20 44.36 42.85
Fixed Asset Turnover
32.46 35.13 41.43 43.47 0.00 0.00 0.00 37.96 17.08 17.07 17.60
Accounts Payable Turnover
5.95 5.58 5.70 5.55 5.74 5.26 5.43 5.60 5.82 6.16 6.83
Days Sales Outstanding (DSO)
72.20 66.80 62.59 66.38 59.40 57.45 114.94 115.08 56.49 55.58 56.88
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 6.01 17.12 16.63 8.26 8.23 8.52
Days Payable Outstanding (DPO)
122.61 65.40 64.04 65.73 63.62 69.34 134.38 65.15 62.67 59.26 53.41
Cash Conversion Cycle (CCC)
10.90 1.41 -1.44 0.65 -4.22 -5.87 -2.31 1.42 2.08 4.54 11.99
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,496 6,065 6,121 6,039 5,735 8,091 8,693 8,757 8,163 8,187 8,502
Invested Capital Turnover
5.13 1.86 1.67 1.68 1.88 1.78 3.27 3.30 1.82 2.04 2.05
Increase / (Decrease) in Invested Capital
-954 4,569 56 -82 -304 2,356 602 64 -594 24 221
Enterprise Value (EV)
2,307 9,701 11,541 10,017 15,493 18,425 16,413 18,465 18,687 23,410 27,044
Market Capitalization
1,882 6,778 8,807 7,217 13,171 14,196 12,011 14,007 14,725 19,635 23,458
Book Value per Share
$14.42 $20.85 $22.28 $22.09 $24.11 $27.14 $30.58 $31.45 $30.55 $33.07 $38.45
Tangible Book Value per Share
($2.21) ($20.46) ($16.26) ($14.72) ($14.33) ($25.77) ($25.87) ($24.50) ($18.75) ($16.41) ($14.74)
Total Capital
2,149 6,434 6,494 6,435 6,403 8,615 9,420 9,273 8,940 9,130 9,610
Total Debt
1,081 3,287 3,111 3,124 2,986 4,744 5,076 4,920 4,682 4,670 4,648
Total Long-Term Debt
1,079 3,225 3,056 3,052 2,925 4,644 4,593 3,928 4,664 4,052 4,628
Net Debt
425 2,911 2,721 2,797 2,318 4,220 4,349 4,404 3,905 3,727 3,540
Capital Expenditures (CapEx)
29 26 73 73 25 171 104 123 207 147 125
Debt-free, Cash-free Net Working Capital (DFCFNWC)
99 51 137 525 -128 8.00 146 172 256 449 899
Debt-free Net Working Capital (DFNWC)
755 427 527 852 540 532 873 688 1,033 1,392 2,007
Net Working Capital (NWC)
753 365 472 780 479 432 390 -304 1,015 774 1,987
Net Nonoperating Expense (NNE)
173 69 154 115 36 163 145 158 113 143 153
Net Nonoperating Obligations (NNO)
428 2,918 2,738 2,728 2,318 4,220 4,349 4,404 3,905 3,727 3,540
Total Depreciation and Amortization (D&A)
62 122 350 257 234 282 325 333 331 290 290
Debt-free, Cash-free Net Working Capital to Revenue
1.96% 0.72% 1.35% 5.15% -1.15% 0.07% 2.13% 2.39% 1.66% 2.69% 5.23%
Debt-free Net Working Capital to Revenue
14.91% 6.06% 5.18% 8.36% 4.87% 4.33% 12.71% 9.56% 6.69% 8.35% 11.69%
Net Working Capital to Revenue
14.87% 5.18% 4.64% 7.65% 4.32% 3.51% 2.84% -4.22% 6.57% 4.65% 11.57%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $2.39 $2.41 $3.85 $4.66 $4.42 $5.34 $5.00 $1.45 $9.36 $11.31
Adjusted Weighted Average Basic Shares Outstanding
0.00 150.35M 151.46M 146.16M 141.40M 141.89M 140.51M 136.94M 135.78M 131.17M 126.39M
Adjusted Diluted Earnings per Share
$0.00 $2.35 $2.38 $3.80 $4.60 $4.36 $5.27 $4.96 $1.44 $9.22 $11.14
Adjusted Weighted Average Diluted Shares Outstanding
0.00 150.35M 151.46M 146.16M 141.40M 141.89M 140.51M 136.94M 135.78M 131.17M 126.39M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 150.35M 151.46M 146.16M 141.40M 141.89M 140.51M 136.94M 135.78M 131.17M 126.39M
Normalized Net Operating Profit after Tax (NOPAT)
249 398 646 739 709 834 925 896 687 1,407 1,629
Normalized NOPAT Margin
9.84% 5.66% 6.36% 7.25% 6.40% 6.78% 6.74% 12.44% 4.45% 8.44% 9.49%
Pre Tax Income Margin
-5.59% 4.52% 3.86% 5.98% 7.81% 6.35% 14.08% 12.31% 2.61% 9.84% 11.12%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-5.57 4.58 3.81 5.29 7.51 5.28 12.51 5.45 0.00 0.00 0.00
NOPAT to Interest Expense
-2.00 3.66 3.70 5.05 5.31 4.43 4.91 4.28 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
-3.17 4.28 3.29 4.76 7.32 4.33 11.38 4.83 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
-4.77 3.36 3.18 4.53 5.12 3.47 8.70 3.66 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-58.82% 461.38% 54.40% 34.02% 29.55% 30.52% 21.21% 59.45% 100.96% 17.11% 15.53%
Augmented Payout Ratio
-191.95% 471.14% 62.91% 109.28% 97.91% 47.22% 113.57% 215.87% 219.23% 89.53% 80.10%

Quarterly Metrics And Ratios for Leidos

This table displays calculated financial ratios and metrics derived from Leidos' official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/29/2024 6/28/2024 9/27/2024 1/3/2025 4/4/2025 7/4/2025 10/3/2025 1/2/2026 4/3/2026 7/3/2026 10/2/2026
DEI Shares Outstanding
- - - - - - - - 126,392,684.00 125,785,466.00 125,492,209.00
DEI Adjusted Shares Outstanding
- - - - - - - - 126,392,684.00 125,785,466.00 125,492,209.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 2.60 2.81 3.27
Growth Metrics
- - - - - - - - - - -
Revenue Growth
7.46% 7.66% 6.86% 9.67% 6.79% 2.93% 6.66% -3.62% 3.65% 7.17% 3.60%
EBITDA Growth
41.69% 32.37% 332.02% 13.35% 22.63% 17.70% 3.75% 10.18% -6.71% -6.82% 2.63%
EBIT Growth
59.77% 44.55% 254.03% 17.55% 26.38% 20.13% 3.68% 13.03% -8.16% -9.25% 2.62%
NOPAT Growth
52.01% 42.41% 268.98% 18.20% 26.81% 19.91% 2.63% 16.67% -1.98% -6.34% 16.17%
Net Income Growth
72.56% 54.29% 191.41% 22.61% 28.98% 21.30% 1.93% 18.79% -8.22% -9.41% 11.92%
EPS Growth
76.92% 58.00% 192.10% 25.00% 33.82% 27.00% 5.22% 20.95% -7.58% -6.64% 16.31%
Operating Cash Flow Growth
164.29% 128.05% -17.48% -1.64% -48.67% 27.56% 9.89% 68.37% 418.97% 63.17% -26.44%
Free Cash Flow Firm Growth
2,096.57% 1,954.53% 1,070.48% -66.05% -83.88% -107.00% -117.91% -25.29% -1,243.07% -551.34% -1,051.19%
Invested Capital Growth
-8.13% -9.23% 0.21% 0.29% 2.80% 6.19% 5.84% 2.67% 27.32% 10.79% 14.58%
Revenue Q/Q Growth
-0.13% 3.95% 1.40% 4.18% -2.75% 0.19% 5.08% -5.86% 4.59% 3.59% 1.58%
EBITDA Q/Q Growth
9.95% 12.76% 7.12% -14.65% 18.96% 8.22% -5.58% -9.36% 0.72% 8.09% 3.99%
EBIT Q/Q Growth
16.16% 14.39% 8.18% -18.22% 24.88% 8.73% -6.63% -10.84% 1.47% 7.44% 5.58%
NOPAT Q/Q Growth
19.16% 13.20% 10.01% -20.34% 27.83% 7.04% -5.85% -9.44% 7.40% 2.28% 16.79%
Net Income Q/Q Growth
23.04% 14.49% 11.73% -22.10% 29.43% 7.67% -6.11% -9.21% 0.00% 6.27% 16.01%
EPS Q/Q Growth
23.21% 14.49% 13.08% -21.64% 31.90% 8.66% -6.31% -9.93% 0.79% 9.77% 16.73%
Operating Cash Flow Q/Q Growth
-79.28% 493.65% 75.40% -54.42% -80.60% 737.93% 46.30% -30.38% -39.19% 163.46% -34.05%
Free Cash Flow Firm Q/Q Growth
22.89% 14.36% -68.59% -23.09% -41.66% -149.67% 19.66% 317.80% -1,415.26% 71.70% -41.99%
Invested Capital Q/Q Growth
2.40% 0.05% -2.49% 0.39% 4.96% 3.35% -2.82% -1.49% 28.69% -10.07% 0.51%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
16.05% 17.06% 18.19% 15.88% 17.83% 18.39% 18.37% 17.57% 17.30% 17.92% 17.71%
EBITDA Margin
12.23% 13.26% 14.01% 11.48% 14.04% 15.17% 13.63% 13.12% 12.64% 13.19% 13.50%
Operating Margin
10.44% 11.50% 12.32% 9.64% 12.49% 13.43% 11.97% 11.24% 11.55% 11.28% 11.94%
EBIT Margin
10.49% 11.54% 12.32% 9.67% 12.41% 13.47% 11.97% 11.34% 11.00% 11.41% 11.86%
Profit (Net Income) Margin
7.12% 7.84% 8.64% 6.46% 8.60% 9.24% 8.26% 7.96% 7.61% 7.81% 8.92%
Tax Burden Percent
76.90% 76.06% 77.02% 75.20% 76.36% 75.87% 76.24% 78.09% 78.09% 78.94% 85.68%
Interest Burden Percent
88.25% 89.31% 91.09% 88.86% 90.70% 90.40% 90.47% 89.94% 88.64% 86.73% 87.80%
Effective Tax Rate
23.10% 23.94% 22.98% 24.80% 23.64% 24.13% 23.76% 21.91% 21.91% 21.06% 14.32%
Return on Invested Capital (ROIC)
14.45% 15.93% 18.95% 14.78% 19.05% 20.15% 18.85% 17.97% 16.00% 16.77% 19.67%
ROIC Less NNEP Spread (ROIC-NNEP)
13.62% 15.04% 18.00% 13.88% 18.09% 19.14% 17.76% 17.03% 14.78% 15.62% 18.21%
Return on Net Nonoperating Assets (RNNOA)
13.47% 13.81% 15.06% 12.15% 17.51% 16.67% 13.23% 13.31% 16.05% 13.50% 14.92%
Return on Equity (ROE)
27.93% 29.74% 34.01% 26.93% 36.55% 36.82% 32.08% 31.28% 32.04% 30.27% 34.59%
Cash Return on Invested Capital (CROIC)
13.60% 16.09% 16.31% 16.76% 14.70% 11.99% 12.94% 16.61% -7.59% 6.64% 4.18%
Operating Return on Assets (OROA)
12.71% 14.25% 15.36% 12.49% 16.16% 17.37% 15.44% 14.69% 13.34% 13.79% 14.55%
Return on Assets (ROA)
8.62% 9.68% 10.78% 8.34% 11.19% 11.91% 10.65% 10.32% 9.23% 9.44% 10.94%
Return on Common Equity (ROCE)
27.58% 29.38% 33.59% 26.61% 36.13% 36.42% 31.75% 30.96% 31.72% 29.98% 34.25%
Return on Equity Simple (ROE_SIMPLE)
7.68% 9.90% 25.99% 0.00% 31.31% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
319 361 397 317 405 433 408 369 397 406 474
NOPAT Margin
8.03% 8.74% 9.49% 7.25% 9.53% 10.19% 9.13% 8.78% 9.02% 8.90% 10.23%
Net Nonoperating Expense Percent (NNEP)
0.83% 0.89% 0.95% 0.91% 0.95% 1.00% 1.09% 0.93% 1.21% 1.15% 1.46%
Return On Investment Capital (ROIC_SIMPLE)
- - - 3.47% 4.29% 4.42% 4.25% 3.84% 3.48% 3.57% 4.21%
Cost of Revenue to Revenue
83.95% 82.94% 81.81% 84.12% 82.17% 81.61% 81.63% 82.43% 82.70% 82.08% 82.29%
SG&A Expenses to Revenue
5.69% 5.59% 5.90% 6.39% 5.42% 5.10% 6.40% 6.32% 5.07% 6.21% 5.66%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
5.61% 5.57% 6.11% 5.75% 5.35% 4.96% 6.31% 6.30% 5.75% 6.65% 5.77%
Earnings before Interest and Taxes (EBIT)
417 477 516 422 527 573 535 477 484 520 549
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
486 548 587 501 596 645 609 552 556 601 625
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
4.21 4.42 4.66 4.45 4.10 4.54 5.11 4.77 4.00 2.59 2.86
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
1.14 1.23 1.32 1.18 1.03 1.24 1.45 1.37 1.16 0.78 0.83
Price to Earnings (P/E)
55.87 45.13 17.95 15.66 13.10 15.11 17.86 16.20 14.21 9.95 10.41
Dividend Yield
1.13% 1.03% 0.95% 1.05% 1.17% 0.96% 0.82% 0.89% 1.05% 1.55% 1.46%
Earnings Yield
1.79% 2.22% 5.57% 6.39% 7.63% 6.62% 5.60% 6.17% 7.04% 10.05% 9.60%
Enterprise Value to Invested Capital (EV/IC)
2.64 2.82 3.07 2.86 2.54 2.86 3.34 3.18 2.38 1.93 2.05
Enterprise Value to Revenue (EV/Rev)
1.40 1.47 1.54 1.41 1.29 1.49 1.66 1.57 1.50 1.08 1.14
Enterprise Value to EBITDA (EV/EBITDA)
20.23 19.28 12.15 11.03 9.77 10.91 12.26 11.26 11.01 8.21 8.67
Enterprise Value to EBIT (EV/EBIT)
28.58 25.69 14.16 12.78 11.23 12.46 14.01 12.80 12.57 9.44 9.96
Enterprise Value to NOPAT (EV/NOPAT)
49.29 41.85 18.62 16.79 14.73 16.37 18.44 16.74 16.18 12.05 12.29
Enterprise Value to Operating Cash Flow (EV/OCF)
16.62 15.35 17.94 16.82 16.30 17.62 19.13 15.45 13.05 8.27 9.58
Enterprise Value to Free Cash Flow (EV/FCFF)
18.56 16.68 18.85 17.08 17.49 24.57 26.52 19.40 0.00 30.62 52.20
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.08 1.04 1.00 1.05 1.19 1.08 0.94 0.94 1.25 1.13 1.15
Long-Term Debt to Equity
1.07 0.91 0.87 0.91 1.17 1.06 0.94 0.93 1.19 1.13 1.15
Financial Leverage
0.99 0.92 0.84 0.88 0.97 0.87 0.74 0.78 1.09 0.86 0.82
Leverage Ratio
2.96 2.83 2.94 2.96 3.02 2.87 2.79 2.81 3.05 2.91 2.85
Compound Leverage Factor
2.61 2.53 2.68 2.63 2.74 2.60 2.53 2.53 2.71 2.52 2.50
Debt to Total Capital
52.04% 50.90% 50.03% 51.15% 54.40% 52.02% 48.42% 48.37% 55.57% 53.06% 53.56%
Short-Term Debt to Total Capital
0.48% 6.17% 6.34% 6.77% 1.26% 1.21% 0.20% 0.21% 2.81% 0.19% 0.16%
Long-Term Debt to Total Capital
51.56% 44.73% 43.69% 44.38% 53.14% 50.81% 48.22% 48.16% 52.76% 52.86% 53.40%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.61% 0.60% 0.57% 0.53% 0.48% 0.46% 0.47% 0.48% 0.45% 0.46% 0.47%
Common Equity to Total Capital
47.35% 48.50% 49.40% 48.32% 45.12% 47.52% 51.11% 51.16% 43.98% 46.49% 45.97%
Debt to EBITDA
4.30 3.82 2.27 2.20 2.30 2.19 1.98 1.94 2.68 2.60 2.58
Net Debt to EBITDA
3.72 3.15 1.69 1.76 1.92 1.79 1.56 1.47 2.49 2.28 2.31
Long-Term Debt to EBITDA
4.26 3.36 1.98 1.91 2.25 2.14 1.97 1.93 2.55 2.59 2.57
Debt to NOPAT
10.47 8.30 3.47 3.35 3.47 3.29 2.98 2.88 3.94 3.82 3.66
Net Debt to NOPAT
9.05 6.84 2.59 2.67 2.90 2.69 2.35 2.19 3.66 3.35 3.28
Long-Term Debt to NOPAT
10.37 7.29 3.03 2.91 3.39 3.21 2.96 2.87 3.74 3.80 3.65
Altman Z-Score
2.98 3.15 3.25 3.18 3.13 3.42 3.78 3.70 2.94 2.66 2.75
Noncontrolling Interest Sharing Ratio
1.25% 1.21% 1.24% 1.20% 1.16% 1.09% 1.02% 1.00% 1.03% 0.97% 0.96%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.35 1.21 1.23 1.21 1.54 1.62 1.62 1.70 1.40 1.63 1.60
Quick Ratio
1.09 0.98 1.03 0.98 1.27 1.30 1.32 1.35 1.11 1.15 1.13
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1,059 1,211 380 293 171 -85 -68 148 -1,951 -552 -784
Operating Cash Flow to CapEx
370.59% 1,626.09% 2,852.17% 347.67% 263.64% 1,675.86% 2,293.55% 1,151.16% 970.97% 2,478.13% 1,112.77%
Free Cash Flow to Firm to Interest Expense
21.62 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
1.29 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.94 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.21 1.23 1.25 1.29 1.30 1.29 1.29 1.30 1.21 1.21 1.23
Accounts Receivable Turnover
6.01 6.29 6.31 6.57 6.03 6.17 6.11 6.42 5.84 5.99 6.02
Inventory Turnover
43.13 41.94 43.94 44.36 42.15 40.34 41.81 42.85 41.66 63.30 65.15
Fixed Asset Turnover
16.59 16.74 16.89 17.07 17.38 17.43 17.73 17.60 17.84 18.83 18.97
Accounts Payable Turnover
6.04 6.41 6.02 6.16 6.26 6.63 6.42 6.83 6.58 6.93 6.77
Days Sales Outstanding (DSO)
60.75 58.06 57.83 55.58 60.56 59.18 59.77 56.88 62.49 60.89 60.65
Days Inventory Outstanding (DIO)
8.46 8.70 8.31 8.23 8.66 9.05 8.73 8.52 8.76 5.77 5.60
Days Payable Outstanding (DPO)
60.40 56.92 60.60 59.26 58.32 55.01 56.81 53.41 55.46 52.66 53.95
Cash Conversion Cycle (CCC)
8.81 9.85 5.54 4.54 10.90 13.22 11.68 11.99 15.80 13.99 12.31
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
8,359 8,363 8,155 8,187 8,593 8,881 8,631 8,502 10,941 9,839 9,889
Invested Capital Turnover
1.80 1.82 2.00 2.04 2.00 1.98 2.07 2.05 1.77 1.88 1.92
Increase / (Decrease) in Invested Capital
-740 -850 17 24 234 518 476 221 2,348 958 1,258
Enterprise Value (EV)
22,035 23,584 25,057 23,410 21,800 25,401 28,814 27,044 26,002 19,025 20,225
Market Capitalization
17,934 19,676 21,516 19,635 17,464 21,182 25,092 23,458 20,074 13,690 14,775
Book Value per Share
$31.49 $32.95 $34.25 $33.07 $32.45 $36.22 $38.26 $38.45 $39.66 $42.01 $41.21
Tangible Book Value per Share
($18.27) ($16.56) ($15.34) ($16.41) ($17.76) ($17.18) ($15.04) ($14.74) ($32.23) ($26.41) ($27.35)
Total Capital
8,992 9,186 9,340 9,130 9,435 9,811 9,605 9,610 11,398 11,367 11,252
Total Debt
4,679 4,676 4,673 4,670 5,133 5,104 4,651 4,648 6,334 6,031 6,027
Total Long-Term Debt
4,636 4,109 4,081 4,052 5,014 4,985 4,632 4,628 6,014 6,009 6,009
Net Debt
4,046 3,853 3,488 3,727 4,291 4,174 3,677 3,540 5,877 5,283 5,397
Capital Expenditures (CapEx)
17 23 23 86 22 29 31 43 31 32 47
Debt-free, Cash-free Net Working Capital (DFCFNWC)
476 468 290 449 865 1,022 908 899 1,114 1,300 1,291
Debt-free Net Working Capital (DFNWC)
1,109 1,291 1,475 1,392 1,707 1,952 1,882 2,007 1,571 2,048 1,921
Net Working Capital (NWC)
1,066 724 883 774 1,588 1,833 1,863 1,987 1,251 2,026 1,903
Net Nonoperating Expense (NNE)
36 37 35 35 40 40 39 34 62 50 61
Net Nonoperating Obligations (NNO)
4,046 3,853 3,488 3,727 4,291 4,174 3,677 3,540 5,877 4,503 4,664
Total Depreciation and Amortization (D&A)
69 71 71 79 69 72 74 75 72 81 76
Debt-free, Cash-free Net Working Capital to Revenue
3.03% 2.92% 1.78% 2.69% 5.11% 5.99% 5.24% 5.23% 6.43% 7.37% 7.25%
Debt-free Net Working Capital to Revenue
7.06% 8.06% 9.06% 8.35% 10.08% 11.45% 10.86% 11.69% 9.07% 11.61% 10.80%
Net Working Capital to Revenue
6.78% 4.52% 5.42% 4.65% 9.38% 10.75% 10.75% 11.57% 7.22% 11.49% 10.69%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.09 $2.39 $2.72 $2.16 $2.79 $3.03 $2.87 $2.62 $2.60 $2.81 $3.31
Adjusted Weighted Average Basic Shares Outstanding
135.21M 134.71M 133.43M 131.17M 128.72M 128.30M 127.86M 126.39M 125.79M 125.49M 121.99M
Adjusted Diluted Earnings per Share
$2.07 $2.37 $2.68 $2.10 $2.77 $3.01 $2.82 $2.54 $2.56 $2.81 $3.28
Adjusted Weighted Average Diluted Shares Outstanding
135.21M 134.71M 133.43M 131.17M 128.72M 128.30M 127.86M 126.39M 125.79M 125.49M 121.99M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
135.21M 134.71M 133.43M 131.17M 128.72M 128.30M 127.86M 126.39M 125.79M 125.49M 121.99M
Normalized Net Operating Profit after Tax (NOPAT)
322 367 404 318 408 435 411 376 424 427 484
Normalized NOPAT Margin
8.11% 8.87% 9.65% 7.29% 9.61% 10.22% 9.20% 8.93% 9.64% 9.37% 10.46%
Pre Tax Income Margin
9.26% 10.31% 11.22% 8.59% 11.26% 12.18% 10.83% 10.20% 9.75% 9.89% 10.41%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
8.51 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
6.51 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
8.16 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
6.17 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
65.14% 48.53% 17.51% 17.11% 16.35% 15.62% 15.68% 15.53% 15.78% 16.34% 15.91%
Augmented Payout Ratio
183.18% 161.90% 76.06% 89.53% 110.20% 97.36% 89.85% 80.10% 61.80% 68.10% 94.02%

Financials Breakdown Chart

Key Financial Trends

Leidos (NYSE: LDOS) has expanded meaningfully since 2022, but its latest quarter shows some moderation in profitability and a heavier debt burden. Q2 2026 revenue reached $4.56 billion, up from $3.84 billion in Q2 2023 and 7.2% above the restated Q2 2025 figure. However, operating income fell to $514 million from $571 million a year earlier, reducing the operating margin to approximately 11.3% from 13.4%.

Net income attributable to common shareholders was $354 million, or $2.81 per diluted share, in Q2 2026. This was below Q2 2025’s $391 million, or $3.01 per share, but well above Q2 2023’s $207 million, or $1.50 per share. The decline in the latest year-over-year comparison reflects higher selling, general and administrative costs, restructuring charges, interest expense and other costs.

  • Revenue growth has remained positive: Quarterly revenue increased from $3.70 billion in Q4 2022 to $4.56 billion in Q2 2026. The strongest recent growth occurred in Q2 2026, when revenue rose 7.2% year over year.
  • Operating cash flow has improved substantially: Cash flow from operations rose to $793 million in Q2 2026, compared with $486 million in Q2 2025, $374 million in Q2 2024 and $164 million in Q2 2023. After $32 million of capital expenditures, the quarter produced an approximate $761 million operating cash flow less capital expenditures.
  • Cash generation supported shareholder returns: Leidos repurchased $72 million of stock and paid $56 million in dividends during Q2 2026. Repurchases across recent quarters have also helped reduce weighted-average diluted shares to 125.5 million from 128.3 million in Q2 2025 and 137.4 million in Q2 2023.
  • Balance-sheet equity has increased: Total equity and noncontrolling interests reached $5.34 billion in Q2 2026, up from $4.71 billion in Q2 2025 and $4.53 billion in Q2 2023. Retained earnings have also grown steadily, reaching $5.22 billion.
  • Short-term liquidity is adequate: Current assets of $5.25 billion exceeded current liabilities of $3.22 billion at the end of Q2 2026, producing a current ratio of approximately 1.6. Cash also increased sequentially to $748 million from $457 million at the end of Q1 2026.
  • Working-capital movements boosted the latest cash flow: Changes in operating assets and liabilities contributed $329 million to Q2 2026 operating cash flow, compared with a $164 million use of cash in Q1. This helped produce the quarter’s strong cash generation, but investors should determine whether the benefit is recurring.
  • Acquisition activity has changed the company’s asset mix: Leidos recorded $2.34 billion of acquisition spending in Q1 2026. Goodwill stood at $7.66 billion in Q2 2026, up from $6.36 billion in Q2 2025, while intangible assets totaled $943 million. Future returns will depend on whether the acquired businesses generate sufficient earnings and cash flow.
  • Profit margins have retreated from their 2025 peak: Q2 2026 gross margin was approximately 17.9%, compared with 18.4% in Q2 2025, while operating margin fell to 11.3% from 13.4%. SG&A expense increased to $283 million from $217 million over the same period, and restructuring charges remained elevated at $27 million.
  • Debt is materially higher than in earlier periods: Total short- and long-term debt was approximately $6.03 billion in Q2 2026, compared with $4.89 billion in Q2 2025 and $4.68 billion in Q2 2024. Net debt was approximately $5.28 billion after subtracting cash, increasing financial risk and interest-rate sensitivity.
  • Interest costs are pressuring earnings: Interest and investment expense was a $69 million net cost in Q2 2026, compared with $55 million in Q2 2025. Cash interest paid was $44 million during the latest quarter, and higher debt could continue to limit net-income growth even if revenue remains strong.

Overall, the statements present a mixed but improving long-term picture. Leidos has grown revenue, restored strong operating cash generation and reduced its share count. Nevertheless, the latest quarter’s weaker margins, lower earnings and increased leverage are important risks. Investors should monitor post-acquisition profitability, recurring free cash flow and whether debt begins to decline without sacrificing share repurchases or dividends.

11/18/26 07:58 AM ETAI Generated. May Contain Errors.

Leidos Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Leidos' financial year ends in January. Their financial year 2026 ended on January 2, 2026.

Leidos' net income appears to be on an upward trend, with a most recent value of $1.46 billion in 2025, compared with -$323 million in 2015. The previous period was $1.25 billion in 2024. Find out what analysts predict for Leidos in the coming months.

Leidos' total operating income in 2025 was $2.11 billion, based on the following breakdown:
  • Total Gross Profit: $3.10 billion
  • Total Operating Expenses: $985 million

Over the last 10 years, Leidos' total revenue changed from $5.06 billion in 2015 to $17.17 billion in 2025, a change of 239.2%.

In the past 11 quarters, Leidos' cash and equivalents has ranged from $457 million in Q1 2026 to $1.19 billion in Q3 2024, and is currently $630 million as of their latest financial filing in Q3 2026.

Leidos had total debt of $4.65 billion at the end of 2025, a 0.5% decrease from 2024, and a 330.0% increase since 2015.

Over the last 10 years, Leidos' book value per share changed from 14.42 in 2015 to 38.45 in 2025, a change of 166.7%.



Financial statements for NYSE:LDOS last updated on 11/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners